{"kind":"expression","expression":{"expr_id":"1735","doc_id":"1735","label":"Misuse of Drugs (Amendment of Schedule 1) Regulations, 2025 (SL 31 of 2025)","is_as_enacted":"f","commenced_on":null,"superseded_on":null,"valid_from":null,"valid_to":null,"is_current":"t","incorporating":null,"akn_expr_iri":"\/akn\/ky\/act\/amending\/2025\/s031\/eng@2025-01-01","akn_envelope":"{\"_canary\": {\"iri\": {\"work\": \"\/akn\/ky\/act\/amending\/2025\/s031\", \"expression\": \"\/akn\/ky\/act\/amending\/2025\/s031\/eng@2025-01-01\", \"manifestation\": \"\/akn\/ky\/act\/amending\/2025\/s031\/eng@2025-01-01.pdf\"}, \"pdf\": {\"md5\": \"c4de714133e4784e5863cff0b0b3795d\", \"path\": \"\/Users\/q\/kyleg-data\/working\/AMENDING\/2025\/2025-S031\/2025-S031.pdf\", \"pages\": 5, \"filename\": \"2025-S031.pdf\"}, \"errors\": [], \"extraction\": {\"model\": null, \"stats\": {\"word_count\": 311, \"paragraph_count\": 3, \"text_char_count\": 2398}, \"usage\": null, \"method\": \"pymupdf-text\", \"version\": \"kyleg-akn-1.0\", \"extracted_at\": \"2026-06-22\"}, \"classification\": \"text_layer\", \"validation_flags\": [], \"docai_processor_id\": null}, \"akomaNtoso\": {\"act\": {\"body\": [{\"eId\": \"sec_n1\", \"num\": null, \"text\": \"Misuse of Drugs Act (2017 Revision) MISUSE OF DRUGS (AMENDMENT OF SCHEDULE 1) REGULATIONS, 2025 (SL 31 of 2025) SL 31 of 2025 PUBLISHING DETAILS Misuse of Drugs (Amendment of Schedule 1) Regulations, 2025 Regulation 1 SL 31 of 2025 Misuse of Drugs Act (2017 Revision) MISUSE OF DRUGS (AMENDMENT OF SCHEDULE 1) REGULATIONS, 2025 (SL 31 of 2025) In exercise of the powers conferred by section 13(a) of the Misuse of Drugs Act (2017 Revision), the Cabinet makes the following Regulations \u2014\", \"element\": \"section\", \"heading\": null}, {\"eId\": \"sec_1\", \"num\": \"1.\", \"text\": \"Citation 1. These Regulations may be cited as the Misuse of Drugs (Amendment of Schedule 1) Regulations, 2025.\", \"element\": \"section\", \"heading\": null}, {\"eId\": \"sec_2\", \"num\": \"2.\", \"text\": \"Amendment of Schedule 1 to the Misuse of Drugs Act (2017 Revision) \u2013 controlled drugs 2. The Misuse of Drugs Act (2017 Revision) is amended in Schedule 1 as follows \u2014 (a) in Part I, in paragraph 1(a), by inserting the following controlled drugs in the appropriate alphabetical sequence \u2014 \u201cAlpha-methyltryptamine (AMT) Amphetamine Brorphine Butonitazene Cumyl-PeGaClone Diphenidine Regulation 2 Misuse of Drugs (Amendment of Schedule 1) Regulations, 2025 SL 31 of 2025 Ephenidine Ethyleneoxynitazene Etodesnitazene (etazene) Flunitazene Gamma-hydroxybutyrate (GHB) Isotonitazene Ketamine Methoxyphenidine Methylamphetamine Metodesnitazene (metazene) Metonitazene N-Desethyl etonitazene N-Desethyl protonitazene N-Desethylisotonitazene N-Piperidinyl-etonitazene (etonitazepipne) N-Pyrrolidino-etonitazene (etonitazepyne) N-Pyrrolidino protonitazene Protonitazene Psilocybin Remimazolam 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921) 3,4-methylenedioxyamphetamine (MDA) 3,4-methylenedioxymethylamphetamine (MDMA) 3-methoxy-4,5-methylenedioxyamphetamine (MMDA) 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4\u2019- DMAR) 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine)\u201d; (b) in Part II, in paragraph 1(a), by deleting the words \u201cAmphetamine\u201d and \u201cMethylamphetamine\u201d; and Misuse of Drugs (Amendment of Schedule 1) Regulations, 2025 Regulation 2 SL 31 of 2025 (c) in Part IV, in the definition of the words \u201ccannabinol derivatives\u201d, by deleting the words \u201c \u201cCarfentanil\u201d \u201d. Made in Cabinet the 22nd day of August, 2025. Kim Bullings Clerk of the Cabinet\", \"element\": \"section\", \"heading\": null}], \"meta\": {\"notes\": null, \"workflow\": null, \"lifecycle\": {\"source\": \"#cilegis\", \"eventRef\": [{\"eId\": \"e_commence_2025_01_01\", \"date\": \"2025-01-01\", \"type\": \"generation\", \"source\": \"#cilegis\"}]}, \"references\": {\"source\": \"#canary\", \"TLCRole\": [], \"TLCEvent\": [{\"eId\": \"ev_commencement\", \"href\": \"\/akn\/ontology\/canary\/event\/commencement\", \"showAs\": \"commencement\"}], \"TLCPerson\": [], \"TLCConcept\": [{\"eId\": \"inForce\", \"href\": \"\/akn\/ontology\/canary\/concept\/temporal\/in-force\", \"showAs\": \"in force\"}], \"TLCProcess\": [], \"TLCLocation\": [], \"TLCOrganization\": [{\"eId\": \"cilegis\", \"href\": \"\/akn\/ontology\/canary\/organization\/editor\/cilegis\", \"showAs\": \"Cayman Islands legislation mirror (kyleg)\"}]}, \"temporalData\": {\"source\": \"#cilegis\", \"temporalGroup\": [{\"eId\": \"tg_inforce_2025_01_01\", \"timeInterval\": [{\"end\": null, \"start\": \"#e_commence_2025_01_01\", \"duration\": null, \"refersTo\": \"#inForce\"}]}]}, \"classification\": null, \"identification\": {\"source\": \"#cilegis\", \"FRBRWork\": {\"FRBRuri\": \"\/akn\/ky\/act\/amending\/2025\/s031\", \"FRBRdate\": [{\"date\": \"2025-01-01\", \"name\": \"generation\"}], \"FRBRthis\": \"\/akn\/ky\/act\/amending\/2025\/s031\/!main\", \"FRBRalias\": [{\"name\": \"cmsId\", \"value\": \"2025-S031\"}], \"FRBRauthor\": [{\"as\": \"#editor\", \"href\": \"\/akn\/ontology\/canary\/organization\/editor\/cilegis\"}], \"FRBRnumber\": \"S031 of 2025\", \"FRBRcountry\": \"ky\", \"FRBRsubtype\": \"amending\"}, \"FRBRExpression\": {\"FRBRuri\": \"\/akn\/ky\/act\/amending\/2025\/s031\/eng@2025-01-01\", \"FRBRdate\": [{\"date\": \"2025-01-01\", \"name\": \"generation\"}], \"FRBRthis\": \"\/akn\/ky\/act\/amending\/2025\/s031\/eng@2025-01-01\/!main\", \"FRBRauthor\": [{\"as\": \"#editor\", \"href\": \"\/akn\/ontology\/canary\/organization\/editor\/cilegis\"}], \"FRBRlanguage\": \"eng\"}, \"FRBRManifestation\": {\"FRBRuri\": \"\/akn\/ky\/act\/amending\/2025\/s031\/eng@2025-01-01.xml\", \"FRBRdate\": [{\"date\": \"2026-06-22\", \"name\": \"generation\"}], \"FRBRthis\": \"\/akn\/ky\/act\/amending\/2025\/s031\/eng@2025-01-01.xml\", \"FRBRauthor\": [{\"as\": \"#editor\", \"href\": \"\/akn\/ontology\/canary\/organization\/editor\/cilegis\"}], \"FRBRformat\": \"application\/xml\"}}}, \"name\": \"act\", \"header\": {\"title\": \"Misuse of Drugs (Amendment of Schedule 1) Regulations, 2025 (SL 31 of 2025)\", \"actNumber\": \"S031 of 2025\", \"longTitle\": null}}, \"doc\": null, \"bill\": null, \"judgment\": null}}","akn_full_text":"CAYMAN ISLANDS\n\nMisuse of Drugs Act\n(2017 Revision)\nMISUSE OF DRUGS (AMENDMENT OF\nSCHEDULE 1) REGULATIONS, 2025\n(SL 31 of 2025)\nSupplement No. 1 published with Legislation Gazette No. 30 dated 26th August, 2025.\n\u2000\n\nPage 2\nSL 31 of 2025\nc\n\nPUBLISHING DETAILS\n\nMisuse of Drugs (Amendment of Schedule 1) Regulations, 2025\nRegulation 1\n\nc\nSL 31 of 2025\nPage 3\n\nCAYMAN ISLANDS\n\nMisuse of Drugs Act\n(2017 Revision)\nMISUSE OF DRUGS (AMENDMENT OF\nSCHEDULE 1) REGULATIONS, 2025\n(SL 31 of 2025)\nIn exercise of the powers conferred by section 13(a) of the Misuse of Drugs Act (2017\nRevision), the Cabinet makes the following Regulations \u2014\n1.\nCitation\n1.\nThese Regulations may be cited as the Misuse of Drugs (Amendment of Schedule 1)\nRegulations, 2025.\n2.\nAmendment of Schedule 1 to the Misuse of Drugs Act (2017 Revision) \u2013\ncontrolled drugs\n2.\nThe Misuse of Drugs Act (2017 Revision) is amended in Schedule 1 as follows \u2014\n(a)\nin Part I, in paragraph 1(a), by inserting the following controlled drugs in\nthe appropriate alphabetical sequence \u2014\n\u201cAlpha-methyltryptamine (AMT)\nAmphetamine\nBrorphine\nButonitazene\nCumyl-PeGaClone\nDiphenidine\n\nRegulation 2\nMisuse of Drugs (Amendment of Schedule 1) Regulations, 2025\n\nPage 4\nSL 31 of 2025\nc\n\nEphenidine\nEthyleneoxynitazene\nEtodesnitazene (etazene)\nFlunitazene\nGamma-hydroxybutyrate (GHB)\nIsotonitazene\nKetamine\nMethoxyphenidine\nMethylamphetamine\nMetodesnitazene (metazene)\nMetonitazene\nN-Desethyl etonitazene\nN-Desethyl protonitazene\nN-Desethylisotonitazene\nN-Piperidinyl-etonitazene (etonitazepipne)\nN-Pyrrolidino-etonitazene (etonitazepyne)\nN-Pyrrolidino protonitazene\nProtonitazene\nPsilocybin\nRemimazolam\n1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)\n3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide\n(AH-7921)\n3,4-methylenedioxyamphetamine (MDA)\n3,4-methylenedioxymethylamphetamine (MDMA)\n3-methoxy-4,5-methylenedioxyamphetamine (MMDA)\n4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine\n(4,4\u2019-\nDMAR)\n5-MeO-DALT (N,N-diallyl-5-methoxytryptamine)\u201d;\n(b) in Part II, in paragraph 1(a), by deleting the words \u201cAmphetamine\u201d and\n\u201cMethylamphetamine\u201d; and\n\nMisuse of Drugs (Amendment of Schedule 1) Regulations, 2025\nRegulation 2\n\nc\nSL 31 of 2025\nPage 5\n\n(c)\nin Part IV, in the definition of the words \u201ccannabinol derivatives\u201d, by\ndeleting the words \u201c \u201cCarfentanil\u201d \u201d.\nMade in Cabinet the 22nd day of August, 2025.\nKim Bullings\nClerk of the Cabinet","akn_extracted_at":"2026-06-22 15:41:48.748215+00","cms_id":"2025-S031","law_type":"amending","year":"2025","number":"S031","title":"Misuse of Drugs (Amendment of Schedule 1) Regulations, 2025 (SL 31 of 2025)","status":"spent"},"provenance":{"files":[{"file_id":"6575","expr_id":"1735","kind":"akn_xml","filename":"2025-S031.akn.xml","source_url":null,"storage_path":"\/Users\/q\/kyleg-data\/working\/AMENDING\/2025\/2025-S031\/2025-S031.akn.xml","content_md5":"0bdbaea68a8739106123f9c6b08c90e7","byte_size":"5169","http_last_modified":null,"fetched_at":"2026-06-22 15:41:48.789197+00"},{"file_id":"3469","expr_id":"1735","kind":"pristine_pdf","filename":"2025-S031.pdf","source_url":"\/cms\/images\/LEGISLATION\/AMENDING\/2025\/2025-S031\/2025-S031.pdf","storage_path":"\/Users\/q\/kyleg-data\/pristine\/AMENDING\/2025\/2025-S031\/2025-S031.pdf","content_md5":"c4de714133e4784e5863cff0b0b3795d","byte_size":"206177","http_last_modified":null,"fetched_at":"2026-06-16 04:01:10.978584+00"},{"file_id":"3470","expr_id":"1735","kind":"working_pdf","filename":"2025-S031.pdf","source_url":"\/cms\/images\/LEGISLATION\/AMENDING\/2025\/2025-S031\/2025-S031.pdf","storage_path":"\/Users\/q\/kyleg-data\/working\/AMENDING\/2025\/2025-S031\/2025-S031.pdf","content_md5":"c4de714133e4784e5863cff0b0b3795d","byte_size":"206177","http_last_modified":null,"fetched_at":"2026-06-16 04:01:10.978584+00"}],"paragraph_count":8,"latest_history":null},"quality":{"expr_id":"1735","doc_id":"1735","quality_state":"needs_review","quality_score":"84","needs_human_review":"t","deterministic_categories":"{duplicate_text,page_header_footer_noise}","llm_categories":"{}","repair_actions":"{collapse_duplicate_text,strip_page_furniture}","finding_severity_counts":"{\"low\": 1, \"medium\": 1}","finding_summary":"repeated line furniture detected: sl 31 of 2025 x6; misuse of drugs amendment of schedule 1 regulation x3; duplicate-line ratio is 16.46%","assessed_at":"2026-06-22 15:29:46.497893+00","updated_at":"2026-06-22 15:29:46.497893+00"}}